HomeRAPT • NASDAQ
add
Rapt Therapeutics Inc
Previous close
$1.32
Day range
$1.16 - $1.31
Year range
$0.79 - $27.35
Market cap
42.30M USD
Avg Volume
6.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.79M | -41.66% |
Net income | -18.43M | 41.25% |
Net profit margin | — | — |
Earnings per share | -0.47 | 42.68% |
EBITDA | -19.49M | 41.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 97.90M | -47.01% |
Total assets | 108.46M | -45.69% |
Total liabilities | 12.96M | -51.86% |
Total equity | 95.51M | — |
Shares outstanding | 34.96M | — |
Price to book | 0.48 | — |
Return on assets | -41.99% | — |
Return on capital | -45.90% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -18.43M | 41.25% |
Cash from operations | -17.62M | 19.48% |
Cash from investing | 18.44M | -28.37% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 823.00K | -79.27% |
Free cash flow | -10.95M | -7.64% |
About
Founded
2015
Headquarters
Website
Employees
70
